A lyophilized peptide looks like it should ignore the weather. It is a dry cake in a sealed vial, not a solution sloshing in a tube. So the obvious question is fair: if freeze-drying already pulled most of the water out, why does anyone put cold packs in the box?
The short answer is that “dry” is not “inert,” and “cold pack” is not automatically a pharmaceutical cold chain. Temperature still changes how mobile the leftover water is in that cake. Moisture still changes whether the cake stays a glass or starts to behave more like a rubber. Last-mile heat is real. None of that is a claim about a person. It is a claim about the solid you are trying to keep as the same chemical the COA described.
What lyophilization actually does
Lyophilization (freeze-drying) converts a frozen solution into a porous solid by removing ice through sublimation, then removing additional water by desorption. The point of the process, in pharmaceutical formulation science, is to put a peptide or protein into a low-moisture amorphous solid that can be stored longer than the same molecule in water.
John Carpenter, Michael Pikal, Byeong Chang, and Theodore Randolph, writing in Pharmaceutical Research in 1997, put the storage problem in physical terms. In the dried solid, the glass transition temperature (Tg) of the amorphous phase that holds the protein needs to sit above the temperatures the product will see. Water plasticizes that amorphous phase. Low residual moisture is required so Tg stays above the highest temperature expected in shipping and storage. They note that shipping and storage temperatures can exceed 40 °C. They also treat residual moisture on the order of about 1 g of water per 100 g of dried solid as the kind of low-moisture target associated with an intact cake.
That paper is about designed protein drug products, with excipients and a development team. A research-peptide vial is usually a much thinner story: a lyophilized peptide, a stopper, a label. The physics still applies. If water is in the cake, it can lower Tg. If the cake is held above Tg, molecular mobility rises. Chemical reactions that were slow in a glass get a vote.
Moisture is not a side issue
Two classic lines of work are worth keeping straight, because internet posts often collapse them into “keep it cold” or “keep it dry” as if those were slogans.
Water as plasticizer. In freeze-dried amorphous materials, added water drops Tg. Carpenter and colleagues treated that as the reason residual moisture has to stay low enough that Tg remains above the heat the package will see.
Water as a chemical participant. Peptides deamidate, hydrolyze, and otherwise react in ways that involve water. Lai, Hageman, Schowen, Borchardt, and Topp, studying an asparagine-containing model hexapeptide in lyophilized polymer matrices (Journal of Pharmaceutical Sciences, 1999), found that raising moisture and plasticizer increased deamidation. In glassy systems with similar Tg, more water still increased deamidation, which they interpreted as a solvent or medium effect, not only a mobility effect. Water also changed the product distribution of the breakdown chemistry.
Costantino, Langer, and Klibanov reported moisture-induced aggregation of lyophilized insulin in the solid state (Pharmaceutical Research, 1994). Aggregation is a physical change as well as a chemical one. A sealed cake can still go wrong if water is available.
None of those papers says “ice packs fix peptides.” They say the solid-state is a system of temperature, water, and mobility. Shipping is just a poorly controlled chapter of that system.
Heat, cycling, and the last mile
A sealed lyophilized vial is more forgiving in transit than the same peptide in solution. That is why some life-science suppliers ship many freeze-dried reagents at ambient temperature for short hauls and then tell the receiving lab to put the unopened vial into cold storage. Short ambient exposure is not the same thing as a week in a hot trailer, a metal mailbox, or a warehouse without temperature control.
What cold packaging is trying to do, when it is done in good faith, is keep the cake closer to the temperature range where the amorphous solid stays a glass. Summer last-mile is the practical enemy: pavement, aircraft holds, and trucks that are not validated refrigerators. A gel pack is a buffer, not a data logger. Unless the shipper recorded temperature, nobody can claim a “validated cold chain” in the pharmaceutical sense. They can claim they reduced the time the vial spent at the hot end of the range.
Temperature cycling adds a second problem that is easy to miss. If a vial is cold, then warm, then cold, and the seal is not perfect, humid air can move. Opening a still-cold vial in a humid room is a known way to put liquid water onto a dry cake (condensation on a cold surface). That is a receiving-lab issue more than a courier issue, but it is the same water. The conservative handling fact is simple: let a sealed vial equilibrate before you open it, so you are not raining on the cake. That is about keeping the solid dry for the next assay. It is not a reconstitution protocol.
Cold shipping vs “standard” shipping, without the folklore
Claim you will hear
What the chemistry actually supports
Lyophilized peptides cannot be damaged by heat.
False as an absolute. Residual water plus heat raises mobility and can accelerate solid-state chemistry.
Ice packs are always required.
Not a universal law. Short ambient transit of a well-sealed, dry cake is common in the reagent industry. Sequence, residual moisture, and duration still matter.
A cold pack is a pharmaceutical cold chain.
Not by itself. A cold chain is specified, monitored, and documented. A pack is a thermal buffer.
If the box feels warm on arrival, the lot is ruined.
You cannot know that from the carton temperature alone. You also cannot know the opposite. The COA describes the lot before shipment, not after an unknown heat history.
Moisture does not matter because the vial was freeze-dried.
Freeze-drying reduces water. It does not make the solid indifferent to the water that remains or the water that later enters.
Sequence matters too, even when we stay away from protocols. Asparagine and glutamine can deamidate. Methionine and cysteine can oxidize. Those liabilities are textbook peptide chemistry (Manning, Patel, and Borchardt’s 1989 review of protein pharmaceutical stability is the usual starting citation). A catalog that does not publish residual moisture, and a COA that never ran Karl Fischer, leaves you without the number Carpenter’s Tg argument wants. Cold packaging is then a conservative control on the variable you can still influence in transit: temperature.
What this does not tell you
It does not tell you how to store a solution after you have added diluent. It does not tell you that a cold pack “keeps potency” for a person. It does not turn a research reagent into a labeled drug product with a stability program.
If you want the paperwork side of “is this still the lot we tested,” start with whether the vial lot matches the COA, then with whether identity and purity were measured orthogonally. That is how to read a peptide COA. For the intended-use sentence that belongs on the vial in the first place, see what research use only means.
References
Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14(8):969-975.
Lai MC, Hageman MJ, Schowen RL, Borchardt RT, Topp EM. Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone). J Pharm Sci. 1999;88(10):1073-1080.
Why Research Peptides Are Shipped Cold
A lyophilized peptide looks like it should ignore the weather. It is a dry cake in a sealed vial, not a solution sloshing in a tube. So the obvious question is fair: if freeze-drying already pulled most of the water out, why does anyone put cold packs in the box?
The short answer is that “dry” is not “inert,” and “cold pack” is not automatically a pharmaceutical cold chain. Temperature still changes how mobile the leftover water is in that cake. Moisture still changes whether the cake stays a glass or starts to behave more like a rubber. Last-mile heat is real. None of that is a claim about a person. It is a claim about the solid you are trying to keep as the same chemical the COA described.
What lyophilization actually does
Lyophilization (freeze-drying) converts a frozen solution into a porous solid by removing ice through sublimation, then removing additional water by desorption. The point of the process, in pharmaceutical formulation science, is to put a peptide or protein into a low-moisture amorphous solid that can be stored longer than the same molecule in water.
John Carpenter, Michael Pikal, Byeong Chang, and Theodore Randolph, writing in Pharmaceutical Research in 1997, put the storage problem in physical terms. In the dried solid, the glass transition temperature (Tg) of the amorphous phase that holds the protein needs to sit above the temperatures the product will see. Water plasticizes that amorphous phase. Low residual moisture is required so Tg stays above the highest temperature expected in shipping and storage. They note that shipping and storage temperatures can exceed 40 °C. They also treat residual moisture on the order of about 1 g of water per 100 g of dried solid as the kind of low-moisture target associated with an intact cake.
That paper is about designed protein drug products, with excipients and a development team. A research-peptide vial is usually a much thinner story: a lyophilized peptide, a stopper, a label. The physics still applies. If water is in the cake, it can lower Tg. If the cake is held above Tg, molecular mobility rises. Chemical reactions that were slow in a glass get a vote.
Moisture is not a side issue
Two classic lines of work are worth keeping straight, because internet posts often collapse them into “keep it cold” or “keep it dry” as if those were slogans.
Water as plasticizer. In freeze-dried amorphous materials, added water drops Tg. Carpenter and colleagues treated that as the reason residual moisture has to stay low enough that Tg remains above the heat the package will see.
Water as a chemical participant. Peptides deamidate, hydrolyze, and otherwise react in ways that involve water. Lai, Hageman, Schowen, Borchardt, and Topp, studying an asparagine-containing model hexapeptide in lyophilized polymer matrices (Journal of Pharmaceutical Sciences, 1999), found that raising moisture and plasticizer increased deamidation. In glassy systems with similar Tg, more water still increased deamidation, which they interpreted as a solvent or medium effect, not only a mobility effect. Water also changed the product distribution of the breakdown chemistry.
Costantino, Langer, and Klibanov reported moisture-induced aggregation of lyophilized insulin in the solid state (Pharmaceutical Research, 1994). Aggregation is a physical change as well as a chemical one. A sealed cake can still go wrong if water is available.
None of those papers says “ice packs fix peptides.” They say the solid-state is a system of temperature, water, and mobility. Shipping is just a poorly controlled chapter of that system.
Heat, cycling, and the last mile
A sealed lyophilized vial is more forgiving in transit than the same peptide in solution. That is why some life-science suppliers ship many freeze-dried reagents at ambient temperature for short hauls and then tell the receiving lab to put the unopened vial into cold storage. Short ambient exposure is not the same thing as a week in a hot trailer, a metal mailbox, or a warehouse without temperature control.
What cold packaging is trying to do, when it is done in good faith, is keep the cake closer to the temperature range where the amorphous solid stays a glass. Summer last-mile is the practical enemy: pavement, aircraft holds, and trucks that are not validated refrigerators. A gel pack is a buffer, not a data logger. Unless the shipper recorded temperature, nobody can claim a “validated cold chain” in the pharmaceutical sense. They can claim they reduced the time the vial spent at the hot end of the range.
Temperature cycling adds a second problem that is easy to miss. If a vial is cold, then warm, then cold, and the seal is not perfect, humid air can move. Opening a still-cold vial in a humid room is a known way to put liquid water onto a dry cake (condensation on a cold surface). That is a receiving-lab issue more than a courier issue, but it is the same water. The conservative handling fact is simple: let a sealed vial equilibrate before you open it, so you are not raining on the cake. That is about keeping the solid dry for the next assay. It is not a reconstitution protocol.
Cold shipping vs “standard” shipping, without the folklore
Sequence matters too, even when we stay away from protocols. Asparagine and glutamine can deamidate. Methionine and cysteine can oxidize. Those liabilities are textbook peptide chemistry (Manning, Patel, and Borchardt’s 1989 review of protein pharmaceutical stability is the usual starting citation). A catalog that does not publish residual moisture, and a COA that never ran Karl Fischer, leaves you without the number Carpenter’s Tg argument wants. Cold packaging is then a conservative control on the variable you can still influence in transit: temperature.
What this does not tell you
It does not tell you how to store a solution after you have added diluent. It does not tell you that a cold pack “keeps potency” for a person. It does not turn a research reagent into a labeled drug product with a stability program.
If you want the paperwork side of “is this still the lot we tested,” start with whether the vial lot matches the COA, then with whether identity and purity were measured orthogonally. That is how to read a peptide COA. For the intended-use sentence that belongs on the vial in the first place, see what research use only means.
References
For laboratory research only. Not for human or veterinary use.
Last reviewed: 2026-10-15